Natera, Inc. splits its revenue into 2 lines in its filings. The largest line in Q3 of fiscal 2026, the quarter ended Sep 30, 2026 was Product at $790.0 million, 99% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Sep 30, 2026
|
Q3 FY2026
Sep 30, 2026
|
Q2 FY2026
Jun 30, 2026
|
Q1 FY2026
Mar 31, 2026
|
Q4 FY2025
Dec 31, 2025
|
Q3 FY2025
Sep 30, 2025
|
Q2 FY2025
Jun 30, 2025
|
Q1 FY2025
Mar 31, 2025
|
Q4 FY2024
Dec 31, 2024
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2,909
|
794
|
753
|
697
|
665
|
592
|
547
|
502
|
476
|
| Product |
2,893
+37.3%
share 99.5%
|
790
+33.9%
share 99.5%
|
748
+37.4%
share 99.4%
|
694
+38.8%
share 99.6%
|
661
+39.8%
share 99.3%
|
590
share 99.7%
|
544
share 99.6%
|
500
share 99.6%
|
473
share 99.3%
|
| Licensing And Other |
16
+75.0%
share 0.5%
|
4
+101.4%
share 0.5%
|
5
+121.9%
share 0.6%
|
3
+54.7%
share 0.4%
|
4
+37.7%
share 0.7%
|
2
share 0.3%
|
2
share 0.4%
|
2
share 0.4%
|
3
share 0.7%
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- NTRA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Austin, TX
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1604821
- Former names
- Natera, Inc. (until Nov 6, 2026)
Other Services-Medical Laboratories companies
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
- CareDx, Inc. CDNA
Source: SEC EDGAR filings. This is company-reported data, not investment advice.